{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:51:03Z","timestamp":1782946263101,"version":"3.54.5"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1093\/jac\/dku036","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T02:01:08Z","timestamp":1393380068000},"page":"1551-1558","source":"Crossref","is-referenced-by-count":16,"title":["Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication"],"prefix":"10.1093","volume":"69","author":[{"given":"Sumayah","family":"Salie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Jen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Semenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muazzam","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"key\n\t\t\t\t20170511115647_DKU036C1","first-page":"1","article-title":"Executive summary","author":"WHO","year":"2011","journal-title":"Global Tuberculosis Control"},{"key":"key\n\t\t\t\t20170511115647_DKU036C2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511115647_DKU036C3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijantimicag.2009.12.019","article-title":"Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!","volume":"35","author":"Amaral","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115647_DKU036C4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"van den Boogaard","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1753465812452193","article-title":"New treatment options for multidrug-resistant tuberculosis","volume":"6","author":"Field","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"key\n\t\t\t\t20170511115647_DKU036C6","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.bmcl.2006.11.091","article-title":"Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives","volume":"17","author":"Bate","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170511115647_DKU036C7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkr500","article-title":"Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine","volume":"67","author":"Garc\u0131","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C8","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/AAC.01601-09","article-title":"In vitro interactions between new antitubercular drug candidates","volume":"54","author":"Reddy","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis","volume":"47","author":"Ordway","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/40.3.319","article-title":"The potential management of resistant infections with non-antibiotics","volume":"40","author":"Kristiansen","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.01033-06","article-title":"Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei","volume":"51","author":"Chan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","article-title":"Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis","volume":"38","author":"Amaral","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-8579(00)00199-0","article-title":"Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis","volume":"16","author":"Bettencourt","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115647_DKU036C14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jac\/47.5.505","article-title":"Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy","volume":"47","author":"Amaral","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","article-title":"Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines","volume":"17","author":"Viveiros","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115647_DKU036C16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","article-title":"Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus","volume":"47","author":"Kaatz","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dks483","article-title":"Antitubercular pharmacodynamics of phenothiazines","volume":"68","author":"Warman","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C18","first-page":"118","article-title":"Thioridazine: an old neuroleptic effective against totally drug resistant tuberculosis","volume":"25","author":"Amaral","year":"2012","journal-title":"Acta M\u00e9d Port"},{"key":"key\n\t\t\t\t20170511115647_DKU036C19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijantimicag.2006.10.013","article-title":"In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis","volume":"29","author":"Martins","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115647_DKU036C20","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.ejmech.2011.05.013","article-title":"Recent progress in biological activities of synthesized phenothiazines","volume":"46","author":"Pluta","year":"2011","journal-title":"Eur J Med Chem"},{"key":"key\n\t\t\t\t20170511115647_DKU036C21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","article-title":"Chemical structure of phenothiazines and their biological activity","volume":"64","author":"Jaszczyszyn","year":"2012","journal-title":"Pharmacol Rep"},{"key":"key\n\t\t\t\t20170511115647_DKU036C22","doi-asserted-by":"crossref","first-page":"11456","DOI":"10.1074\/jbc.M508844200","article-title":"Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2)","volume":"281","author":"Yano","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511115647_DKU036C23","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S1734-1140(12)70957-X","article-title":"Autoinduction of the metabolism of phenothiazine neuroleptics in a primary culture of human hepatocytes","volume":"64","author":"W\u00f3jcikowski","year":"2012","journal-title":"Pharmacol Rep"},{"key":"key\n\t\t\t\t20170511115647_DKU036C24","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1128\/AAC.47.12.3682-3687.2003","article-title":"Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter","volume":"47","author":"Changsen","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115647_DKU036C25","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.bmcl.2007.03.064","article-title":"Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors","volume":"17","author":"Madrid","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170511115647_DKU036C26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijantimicag.2012.01.012","article-title":"Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections","volume":"39","author":"Amaral","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115647_DKU036C27","first-page":"34","article-title":"Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus","volume":"20","author":"Ordway","year":"2002"},{"key":"key\n\t\t\t\t20170511115647_DKU036C28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239036","article-title":"Chlorpromazine: a drug potentially useful for treating mycobacterial infections","volume":"38","author":"Crowle","year":"1992","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170511115647_DKU036C29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/taap.1999.8688","article-title":"The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions","volume":"158","author":"Daniel","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"key\n\t\t\t\t20170511115647_DKU036C30","first-page":"409","article-title":"Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB","volume":"24","author":"Amaral","year":"2010","journal-title":"In Vivo"},{"key":"key\n\t\t\t\t20170511115647_DKU036C31","first-page":"69","article-title":"Inhibitors of Ca2+ and K+ transport enhance intracellular killing of M. tuberculosis by non-killing macrophages","volume":"22","author":"Martins","year":"2008","journal-title":"In Vivo"},{"key":"key\n\t\t\t\t20170511115647_DKU036C32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000325297","article-title":"Importance of phagosomal functionality for growth restriction of Mycobacterium tuberculosis in primary human macrophages","volume":"3","author":"Welin","year":"2011","journal-title":"J Innate Immun"},{"key":"key\n\t\t\t\t20170511115647_DKU036C33","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.4049\/jimmunol.166.5.3392","article-title":"Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages","volume":"166","author":"Malik","year":"2001","journal-title":"J Immunol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/69\/6\/1551\/16863795\/dku036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T12:08:45Z","timestamp":1503490125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,2,25]]},"published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku036","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}